{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antivirals", "drug development", "lignans", "mechanism"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31906391", "DateCompleted": {"Year": "2020", "Month": "06", "Day": "15"}, "DateRevised": {"Year": "2021", "Month": "08", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "01"}], "Language": ["eng"], "ELocationID": ["183", "10.3390/molecules25010183"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "25", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Jan", "Day": "01"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Lignans and Their Derivatives from Plants as Antivirals.", "Abstract": {"AbstractText": ["Lignans are widely produced by various plant species; they are a class of natural products that share structural similarity. They usually contain a core scaffold that is formed by two or more phenylpropanoid units. Lignans possess diverse pharmacological properties, including their antiviral activities that have been reported in recent years. This review discusses the distribution of lignans in nature according to their structural classification, and it provides a comprehensive summary of their antiviral activities. Among them, two types of antiviral lignans-podophyllotoxin and bicyclol, which are used to treat venereal warts and chronic hepatitis B (CHB) in clinical, serve as examples of using lignans for antivirals-are discussed in some detail. Prospects of lignans in antiviral drug discovery are also discussed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China."}, {"Identifier": [], "Affiliation": "Qingdao Academy of Chinese Medicinal Sciences, Shandong University of Traditional Chinese Medicine, Qingdao 266122, China."}, {"Identifier": [], "Affiliation": "Research Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China."}], "LastName": "Cui", "ForeName": "Qinghua", "Initials": "Q"}, {"Identifier": ["0000-0002-9172-7824"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China."}, {"Identifier": [], "Affiliation": "Qingdao Academy of Chinese Medicinal Sciences, Shandong University of Traditional Chinese Medicine, Qingdao 266122, China."}, {"Identifier": [], "Affiliation": "Research Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China."}], "LastName": "Du", "ForeName": "Ruikun", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China."}], "LastName": "Liu", "ForeName": "Miaomiao", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA."}], "LastName": "Rong", "ForeName": "Lijun", "Initials": "L"}], "GrantList": [{"GrantID": "2018ZX09711001", "Agency": "The Drug Innovation Major Project", "Country": ""}, {"GrantID": "2017CXGC1309", "Agency": "the Key Research and Development Projects of Science and Technology Department of Shandong Province", "Country": ""}, {"GrantID": "ZR2019MH078", "Agency": "handong Provincial Natural Science Foundation, China", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "4,4',9-trihydroxy-3,3'-dimethoxy-9,9'-epoxylignan"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzodioxoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Biphenyl Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Furans"}, {"RegistryNumber": "0", "NameOfSubstance": "Lignans"}, {"RegistryNumber": "53YET703F2", "NameOfSubstance": "terameprocol"}, {"RegistryNumber": "7BO8G1BYQU", "NameOfSubstance": "Masoprocol"}, {"RegistryNumber": "886IAL08GN", "NameOfSubstance": "phillygenin"}, {"RegistryNumber": "9734122TH2", "NameOfSubstance": "bicyclol"}, {"RegistryNumber": "L36H50F353", "NameOfSubstance": "Podophyllotoxin"}, {"RegistryNumber": "W4PN5LDP26", "NameOfSubstance": "diphyllin"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Benzodioxoles"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Biphenyl Compounds"}, {"QualifierName": [], "DescriptorName": "Drug Development"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Furans"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Lignans"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Masoprocol"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Podophyllotoxin"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Teponno R.B., Kusari S., Spiteller M. Recent advances in research on lignans and neolignans. Nat. Prod. Rep. 2016;33:1044\u20131092. doi: 10.1039/C6NP00021E.", "ArticleIdList": ["10.1039/C6NP00021E", "27157413"]}, {"Citation": "Ayres D.C., Loike J.D. Lignans. Chemical, Biological and Clinical Properties. Lignans Chem. Biol. Clin. Prop. 1991;100:1."}, {"Citation": "Kaplan I.W. Condylomata acuminate. New Orleans Med. Surg. J. 1942;94:388\u2013390."}, {"Citation": "Wu X.Q., Li W., Chen J.X., Zhai J.W., Xu H.Y., Ni L., Wu S.S. Chemical Constituents and Biological Activity Profiles on Pleione (Orchidaceae) Molecules. 2019;24:3195. doi: 10.3390/molecules24173195.", "ArticleIdList": ["10.3390/molecules24173195", "PMC6749413", "31484345"]}, {"Citation": "Lu H.L., Liu G.T. Antioxidant activity of dibenzocyclooctene lignans isolated from Schisandraceae. Planta Med. 1992;58:4. doi: 10.1055/s-2006-961473.", "ArticleIdList": ["10.1055/s-2006-961473", "1332091"]}, {"Citation": "Pan J.Y., Chen S.L., Yang M.H., Wu J., Sinkkonen J., Zou K. An update on lignans: Natural products and synthesis. Nat. Prod. Rep. 2009;26:1251\u20131292. doi: 10.1039/b910940d.", "ArticleIdList": ["10.1039/b910940d", "19779640"]}, {"Citation": "Capilla A.S., S\u00e1nchez I., Caignard D.H., Renard P., Pujol M.D. Antitumor agents. Synthesis and biological evaluation of new compounds related to podophyllotoxin, containing the 2,3-dihydro-1,4-benzodioxin system. Eur. J. Med. Chem. 2001;36:11. doi: 10.1016/S0223-5234(01)01231-4.", "ArticleIdList": ["10.1016/S0223-5234(01)01231-4", "11461764"]}, {"Citation": "Kawazoe K., Yutani A., Tamemoto K., Yuasa S., Shibata H., Higuti T., Takaishi Y. Phenylnaphthalene Compounds from the Subterranean Part of Vitex rotundifolia and Their Antibacterial Activity Against Methicillin-Resistant Staphylococcus aureus. J. Nat. Prod. 2001;64:588\u2013591. doi: 10.1021/np000307b.", "ArticleIdList": ["10.1021/np000307b", "11374949"]}, {"Citation": "Hirano T., Wakasugi A., Oohara M., Oka K., Sashida Y. Suppression of mitogen-induced proliferation of human peripheral blood lymphocytes by plant lignans. Planta Med. 1991;57:4. doi: 10.1055/s-2006-960110.", "ArticleIdList": ["10.1055/s-2006-960110", "1663632"]}, {"Citation": "Iwasaki T., Kondo K., Kuroda T., Moritani Y., Yamagata S., Sugiura M., Kikkawa H., Kaminuma O., Ikezawa K. Novel selective PDE IV inhibitors as antiasthmatic agents. synthesis and biological activities of a series of 1-aryl-2,3-bis(hydroxymethyl)naphthalene lignans. J. Med. Chem. 1996;39:9. doi: 10.1021/jm9509096.", "ArticleIdList": ["10.1021/jm9509096", "8709099"]}, {"Citation": "Charlton James L. Antiviral Activity of Lignans. J. Nat. Prod. 1998;61:1447\u20131451. doi: 10.1021/np980136z.", "ArticleIdList": ["10.1021/np980136z", "9834179"]}, {"Citation": "Huang R.L., Huang Y.L., Ou J.C., Chen C.C., Hsu F.L., Chang C. Screening of 25 compounds isolated from Phyllanthus species for anti-human hepatitis B virus in vitro. Phytother Res. 2003;17:449\u2013453. doi: 10.1002/ptr.1167.", "ArticleIdList": ["10.1002/ptr.1167", "12748977"]}, {"Citation": "Pilkington L.I. Lignans: A Chemometric Analysis. Molecules. 2018;23:1666. doi: 10.3390/molecules23071666.", "ArticleIdList": ["10.3390/molecules23071666", "PMC6099669", "29987225"]}, {"Citation": "Kirkman L.M., Lampe J.W., Campbell D.R., Martini M.C., Slavin J.L. Urinary Lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutr. Cancer. 1995;24:12. doi: 10.1080/01635589509514388.", "ArticleIdList": ["10.1080/01635589509514388", "7491293"]}, {"Citation": "Jeffries D.E., Lindsley C.W. Asymmetric Synthesis of Natural and Unnatural Dibenzylbutane Lignans from a Common Intermediate. J. Org. Chem. 2019;84:5974\u20135979. doi: 10.1021/acs.joc.9b00633.", "ArticleIdList": ["10.1021/acs.joc.9b00633", "31002498"]}, {"Citation": "Liu S., Wei W., Shi K., Cao X., Zhou M., Liu Z. In Vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L. J. Ethnopharmacol. 2014;155:1061\u20131067. doi: 10.1016/j.jep.2014.05.064.", "ArticleIdList": ["10.1016/j.jep.2014.05.064", "25009077"]}, {"Citation": "Hernandez D.J., Anderica R.A.C., Pedraza C.J. Paradoxical cellular effects and biological role of the multifaceted compound nordihydroguaiaretic acid. Arch. Pharm. 2014;347:685\u2013697. doi: 10.1002/ardp.201400159.", "ArticleIdList": ["10.1002/ardp.201400159", "25100573"]}, {"Citation": "Z\u00fa\u00f1iga-Toal\u00e1 A., Zatarain-Barr\u00f3n Z.L., Hern\u00e1ndez-Pando R., Negrette-Guzm\u00e1n M., Huerta-Yepez S., Torres I., Pinz\u00f3n E., Tapia E., Pedraza-Chaverri J. Nordihydroguaiaretic acid induces Nrf2 nuclear translocation in vivo and attenuates renal damage and apoptosis in the ischemia and reperfusion model. Phytomedicine. 2013;20:775\u2013779. doi: 10.1016/j.phymed.2013.03.020.", "ArticleIdList": ["10.1016/j.phymed.2013.03.020", "23643094"]}, {"Citation": "Tong W., Ding X., Adrian T. The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun. 2002;296:942\u2013948. doi: 10.1016/S0006-291X(02)02014-4.", "ArticleIdList": ["10.1016/S0006-291X(02)02014-4", "12200139"]}, {"Citation": "Manzanero S., Santro T., Arumugam T.V. Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury. Neurochem. Int. 2013;62:712\u2013718. doi: 10.1016/j.neuint.2012.11.009.", "ArticleIdList": ["10.1016/j.neuint.2012.11.009", "23201332"]}, {"Citation": "Floriano-Sanchez E., Villanueva C., Medina-Campos O.N., Rocha D., S\u00e1nchez-Gonz\u00e1lez D.J., C\u00e1rdenas-Rodr\u00edguez N., Pedraza-Chaverr\u00ed J. Nordihydroguaiaretic acid is a potent in vitro scavenger of peroxynitrite, singlet oxygen, hydroxyl radical, superoxide anion and hypochlorous acid and prevents in vivo ozone-induced tyrosine nitration in lungs. Free Radic Res. 2006;40:523\u2013533. doi: 10.1080/10715760500419365.", "ArticleIdList": ["10.1080/10715760500419365", "16551579"]}, {"Citation": "Soto A.R., Bautista C.P., Syed G.H., Siddiqui A., Del Angel R.M. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus. Antivir. Res. 2014;109:132\u2013140. doi: 10.1016/j.antiviral.2014.07.002.", "ArticleIdList": ["10.1016/j.antiviral.2014.07.002", "25017471"]}, {"Citation": "Syed G.H., Siddiqui A. Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus. Hepatology. 2011;54:1936\u20131946. doi: 10.1002/hep.24619.", "ArticleIdList": ["10.1002/hep.24619", "PMC3236615", "21858850"]}, {"Citation": "Merino-Ramos T., de Oya N.J., Saiz J.-C., Mart\u00edn-Acebes M.A. Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-O-Methyl Nordihydroguaiaretic Acid against West Nile Virus and Zika Virus. Antimicrob. Agents Chemother. 2017:61. doi: 10.1128/AAC.00376-17.", "ArticleIdList": ["10.1128/AAC.00376-17", "PMC5527643", "28507114"]}, {"Citation": "Wang S., Le T.Q., Kurihara N., Chida J., Cisse Y., Yano M., Kido H. Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J. Infect. Dis. 2010;202:991\u20131001. doi: 10.1086/656044.", "ArticleIdList": ["10.1086/656044", "PMC7537608", "20731583"]}, {"Citation": "Oyegunwa A.O., Sikes M.L., Wilson J.R., Scholle F., Laster S.M. Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-kappaB-dependent transcription of TNF-alpha and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA. J. Inflamm. 2010;7:59. doi: 10.1186/1476-9255-7-59.", "ArticleIdList": ["10.1186/1476-9255-7-59", "PMC3002343", "21138578"]}, {"Citation": "Pollara J.J., Laster S.M., Petty I.T. Inhibition of poxvirus growth by Terameprocol, a methylated derivative of nordihydroguaiaretic acid. Antivir. Res. 2010;88:287\u2013295. doi: 10.1016/j.antiviral.2010.09.017.", "ArticleIdList": ["10.1016/j.antiviral.2010.09.017", "20888364"]}, {"Citation": "Chen H., Teng L., Li J.N., Park R., Mold D.E., Gnabre J., Hwu J.R., Tseng W.N., Huang R.C.C. Antiviral Activities of Methylated Nordihydroguaiaretic Acids. 2. Targeting Herpes Simplex Virus Replication by the Mutation Insensitive Transcription Inhibitor Tetra-O-methyl-NDGA. J. Med. Chem. 1998;41:3001\u20133007. doi: 10.1021/jm980182w.", "ArticleIdList": ["10.1021/jm980182w", "9685239"]}, {"Citation": "Gnabre J.N., Brady J.N., Clanton D.J., Ito Y., Dittmer J., Bates R.B., Huang R.C. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans. Proc. Natl. Acad. Sci. USA. 1995;92:11239\u201311243. doi: 10.1073/pnas.92.24.11239.", "ArticleIdList": ["10.1073/pnas.92.24.11239", "PMC40607", "7479972"]}, {"Citation": "Khanna N., Dalby R., Tan M., Arnold S., Stern J., Frazer N. Phase I/II clinical safety studies of terameprocol vaginal ointment. Gynecol. Oncol. 2007;107:554\u2013562. doi: 10.1016/j.ygyno.2007.08.074.", "ArticleIdList": ["10.1016/j.ygyno.2007.08.074", "17905420"]}, {"Citation": "Xu X., Wang D., Ku C., Zhao Y., Cheng H., Liu K.-L., Rong L.-J., Zhang H.-J. Anti-HIV lignans from Justicia procumbens. Chin. J. Nat. Med. 2019;17:945\u2013952. doi: 10.1016/S1875-5364(19)30117-7.", "ArticleIdList": ["10.1016/S1875-5364(19)30117-7", "31882050"]}, {"Citation": "Gao Y., Dong X., Kang T.G. Activity of in vitro anti-influenza virus of arctigenin. Chin. Herb. Med. 2002;33:724\u2013725."}, {"Citation": "Fu L., Xu P., Liu N., Yang Z., Zhang F., Hu Y. Antiviral effect of Arctigenin Compound on Influenza Virus. Tradit. Chin. Drug Res. Clin. Pharmacol. 2008;19:4."}, {"Citation": "Hayashi K., Narutaki K., Nagaoka Y., Hayashi T., Uesato S. Therapeutic Effect of Arctiin and Arctigenin in Immunocompetent and Immunocompromised Mice Infected with Influenza A Virus. Biol. Pharm. Bull. 2010;33:1199\u20131205. doi: 10.1248/bpb.33.1199.", "ArticleIdList": ["10.1248/bpb.33.1199", "20606313"]}, {"Citation": "Schr\u00f6der H.C., Merz H., Steffen R., M\u00fcller W.E., Sarin P.S., Trumm S., Schulz J., Eich E. Differential in vitro anti-HIV activity of natural lignans. Zeitschrift f\u00fcr Naturforschung C. 1990;45:1215\u20131221.", "ArticleIdList": ["1965681"]}, {"Citation": "Eich E., Pertz H., Kaloga M., Schulz J., Pertz H., Eich E., Pommier Y. (\u2212)-Arctigenin as a Lead Structure for Inhibitors of Human Immunodeficiency Virus Type-1 Integrase. J. Med. Chem. 1996;39:86\u201395. doi: 10.1021/jm950387u.", "ArticleIdList": ["10.1021/jm950387u", "8568830"]}, {"Citation": "Kuo Y.C., Kuo Y.H., Lin Y.L., Tsai W.J. Yatein from Chamaecyparis obtusa suppresses herpes simplex virus type 1 replication in HeLa cells by interruption the immediate-early gene expression. Antivir. Res. 2006;70:112\u2013120. doi: 10.1016/j.antiviral.2006.01.011.", "ArticleIdList": ["10.1016/j.antiviral.2006.01.011", "16540181"]}, {"Citation": "Wang Y., Wang X., Xiong Y., Kaushik A.C., Muhammad J., Khan A., Dai H., Wei D.-Q. New strategy for identifying potential natural HIV-1 non-nucleoside reverse transcriptase inhibitors against drug-resistance: An in silico study. J. Biomol. Struct. Dyn. 2019:1\u201315. doi: 10.1080/07391102.2019.1656673.", "ArticleIdList": ["10.1080/07391102.2019.1656673", "31422767"]}, {"Citation": "Chang C., Lien Y., Liu K.C.S.C., Li S.-S. Lignans from Phyllanthus urinaria. Phytochemistry. 2003;63:825\u2013833. doi: 10.1016/S0031-9422(03)00371-6.", "ArticleIdList": ["10.1016/S0031-9422(03)00371-6", "12877924"]}, {"Citation": "Kuo P., Li Y., Wu T. Chemical Constituents and Pharmacology of the Aristolochia species. J. Tradit. Complement. Med. 2012;2:249\u2013266. doi: 10.1016/S2225-4110(16)30111-0.", "ArticleIdList": ["10.1016/S2225-4110(16)30111-0", "PMC3942903", "24716140"]}, {"Citation": "Gangan V., Hussain S.S. Alkaloids from Piper hookeri: Revision of NMR assignments by the application of 2D NMR spectroscopy. J. Pharm. Res. 2011;4:3."}, {"Citation": "Nunomura S., Yoshida M. Lignans and benzoic acid derivatives from pericarps of Virola multinervia (Myristicaceae) Biochem. Syst. Ecol. 2002;30:3. doi: 10.1016/S0305-1978(02)00044-3.", "ArticleIdList": ["10.1016/S0305-1978(02)00044-3"]}, {"Citation": "Schmidt T.J., Hemmati S., Klaes M., Konuklugil B., Mohagheghzadeh A., Ionkova I., Fuss E., Alfermann A.W. Lignans in flowering aerial parts of Linum species\u2014chemodiversity in the light of systematics and phylogeny. Phytochemistry. 2010;71:1714\u20131728. doi: 10.1016/j.phytochem.2010.06.015.", "ArticleIdList": ["10.1016/j.phytochem.2010.06.015", "20655554"]}, {"Citation": "Marcotullio M.C., Pelosi A., Curini M. Hinokinin, an emerging bioactive lignan. Molecules. 2014;19:14862\u201314878. doi: 10.3390/molecules190914862.", "ArticleIdList": ["10.3390/molecules190914862", "PMC6271885", "25232707"]}, {"Citation": "Cheng M.-J., Lee K.-H., Tsai I.-L., Chen I.-S. Two new sesquiterpenoids and anti-HIV principles from the root bark of Zanthoxylum ailanthoides. Bioorg. Med. Chem. 2005;13:5915\u20135920. doi: 10.1016/j.bmc.2005.07.050.", "ArticleIdList": ["10.1016/j.bmc.2005.07.050", "16140017"]}, {"Citation": "Wen C.-C., Kuo Y.-H., Jan J.-T., Liang P.-H., Wang S.-Y., Liu H.-G., Li C.-K., Chang S.-T., Kuo C.-J., Lee S.-S., et al. Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus. J. Med. Chem. 2007;50:4087\u20134095. doi: 10.1021/jm070295s.", "ArticleIdList": ["10.1021/jm070295s", "17663539"]}, {"Citation": "Roz\u00e1lia P., Abrantes M., Serly J., Duarte N., Molnar J., Ferreira M.-J.U. Antitumor-promoting Activity of Lignans: Inhibition of Human Cytomegalovirus IE Gene Expression. Anticancer Res. 2010;30:451\u2013454.", "ArticleIdList": ["20332453"]}, {"Citation": "Chen H., Liu P., Zhang T., Gao Y., Zhang Y., Shen X., Li X., Shen W. Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells. Oncol. Rep. 2018;39:921\u2013928. doi: 10.3892/or.2018.6191.", "ArticleIdList": ["10.3892/or.2018.6191", "PMC5802041", "29328465"]}, {"Citation": "Nesmelova E.F., Razakova D.M., Akhmedzhanova V.I., Bessonova I.A. Diphyllin from Haplophyllum alberti-regelii, H. bucharicum, and H. perforatum. Chem. Nat. Compd. 1983;19:608. doi: 10.1007/BF00576100.", "ArticleIdList": ["10.1007/BF00576100"]}, {"Citation": "S\u00f8rensen M.G., Henriksen K., Neutzsky-Wulff A.V., Dziegiel M.H., Karsdal M.A. Diphyllin, a Novel and Naturally Potent V-ATPase Inhibitor, Abrogates Acidification of the Osteoclastic Resorption Lacunae and Bone Resorption. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2007;22:9. doi: 10.1359/jbmr.070613.", "ArticleIdList": ["10.1359/jbmr.070613", "17576165"]}, {"Citation": "Martinez-Lopez A., Persaud M., Chavez M.P., Zhang H., Rong L., Liu S., Wang T.T., Sarafianos S.G., Diaz-Griffero F. Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus. EBioMedicine. 2019;47:269\u2013283. doi: 10.1016/j.ebiom.2019.08.060.", "ArticleIdList": ["10.1016/j.ebiom.2019.08.060", "PMC6796538", "31501074"]}, {"Citation": "Chen H.-W., Cheng J.X., Liu M.-T., King K., Peng J.Y., Zhang X.-Q., Wang C.-H., Shresta S., Schooley R.T., Liu Y.-T. Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses. Antivir. Res. 2013;99:371\u2013382. doi: 10.1016/j.antiviral.2013.06.014.", "ArticleIdList": ["10.1016/j.antiviral.2013.06.014", "PMC3787953", "23820269"]}, {"Citation": "Susplugas S., Hung N., Bignon J., Thoison O., Kruczynski A., S\u00e9venet T., Gu\u00e9ritte F. Cytotoxic Arylnaphthalene Lignans from a Vietnamese Acanthaceae. Justicia patentiflora. J. Nat. Prod. 2005;68:734\u2013738. doi: 10.1021/np050028u.", "ArticleIdList": ["10.1021/np050028u", "15921419"]}, {"Citation": "Zhang H.-J., Rumschlag-Booms E., Guan Y.-F., Liu K.-L., Wang D.-Y., Li W.-F., Nguyen V.H., Cuong N.M., Soejarto D.D., Fong H.H.S. Anti-HIV diphyllin glycosides from Justicia gendarussa. Phytochemistry. 2017;136:94\u2013100. doi: 10.1016/j.phytochem.2017.01.005.", "ArticleIdList": ["10.1016/j.phytochem.2017.01.005", "28110956"]}, {"Citation": "Zhang H.-J., Rumschlag-Booms E., Guan Y.-F., Wang D.-Y., Liu K.-L., Li W.-F., Nguyen V.H., Cuong N.M., Soejarto D.D., Fong H.H.S. Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa. J. Nat. Prod. 2017;80:1798\u20131807. doi: 10.1021/acs.jnatprod.7b00004.", "ArticleIdList": ["10.1021/acs.jnatprod.7b00004", "28613071"]}, {"Citation": "Zalesak F., Bon D.J.D., Pospisil J. Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances. Pharm. Res. 2019;146:104284. doi: 10.1016/j.phrs.2019.104284.", "ArticleIdList": ["10.1016/j.phrs.2019.104284", "31136813"]}, {"Citation": "Alsdorf W., Seidel C., Bokemeyer C., Oing C. Current pharmacotherapy for testicular germ cell cancer. Expert Opin. Pharm. 2019;20:837\u2013850. doi: 10.1080/14656566.2019.1583745.", "ArticleIdList": ["10.1080/14656566.2019.1583745", "30849243"]}, {"Citation": "Komericki P., Akkilic-Materna M., Strimitzer T., Aberer W. Efficacy and Safety of Imiquimod Versus Podophyllotoxin in the Treatment of Anogenital Warts. Sex. Transm. Dis. 2011;38:3. doi: 10.1097/OLQ.0b013e3181f68ebb.", "ArticleIdList": ["10.1097/OLQ.0b013e3181f68ebb", "20938374"]}, {"Citation": "Ma Z.-J., Lu L., Yang J.-J., Wang X.-X., Su G., Wang Z., Chen G., Sun H., Wang M., Yang Y. Lariciresinol induces apoptosis in HepG2 cells via mitochondrial-mediated apoptosis pathway. Eur. J. Pharm. 2018;821:1\u201310. doi: 10.1016/j.ejphar.2017.12.027.", "ArticleIdList": ["10.1016/j.ejphar.2017.12.027", "29247613"]}, {"Citation": "Zhao D., Wu T.Y., Guan Y.Q., Ma G.X., Zhang J., Shi L.L. Chemical constituents from roots of Stelleropsis tianschanica. China J. Chin. Mater. Med. 2017;42:3379\u20133384.", "ArticleIdList": ["29192450"]}, {"Citation": "Bajpai V.K., Shukla S., Paek W.K., Lim J., Kumar P., Kumar P., Na M.K. Efficacy of (+)-Lariciresinol to Control Bacterial Growth of Staphylococcus aureus and Escherichia coli O157:H7. Front. Microbiol. 2017;8:804. doi: 10.3389/fmicb.2017.00804.", "ArticleIdList": ["10.3389/fmicb.2017.00804", "PMC5413575", "28515721"]}, {"Citation": "Li J., Zhou B., Li C., Chen Q.Y., Wang Y., Li Z., Chen T., Yang C., Jiang B., Zhong Z. Lariciresinol-4-O-beta-d-glucopyranoside from the root of Isatis indigotica inhibits influenza A virus-induced pro-inflammatory response. J. Ethnopharmacol. 2015;174:379\u2013386. doi: 10.1016/j.jep.2015.08.037.", "ArticleIdList": ["10.1016/j.jep.2015.08.037", "26320688"]}, {"Citation": "Zhou B., Li J., Liang X., Yang Z., Jiang Z. Transcriptome profiling of influenza A virus-infected lung epithelial (A549) cells with lariciresinol-4-beta-D-glucopyranoside treatment. PLoS ONE. 2017;12:e0173058.", "ArticleIdList": ["PMC5342222", "28273165"]}, {"Citation": "Liu Z.L., Liu Y.Q., Zhao L., Xu J., Tian X. The phenylpropanoids of Aster flaccidus. Fitoterapia. 2010;81:140\u2013144. doi: 10.1016/j.fitote.2009.08.004.", "ArticleIdList": ["10.1016/j.fitote.2009.08.004", "19686819"]}, {"Citation": "Meng L., Guo Q., Chen M., Jiang J., Li Y., Shi J. Isatindolignanoside A, a glucosidic indole-lignan conjugate from an aqueous extract of the Isatis indigotica roots. Chin. Chem. Lett. 2018;29:1257\u20131260. doi: 10.1016/j.cclet.2017.12.001.", "ArticleIdList": ["10.1016/j.cclet.2017.12.001"]}, {"Citation": "Yang Z., Wang Y., Zheng Z., Zhao S., Zhao J., Lin Q., Li C., Zhu Q., Zhong N. Antiviral activity of Isatis indigotica root-derived clemastanin B against human and avian influenza A and B viruses in vitro. Int. J. Mol. Med. 2013;31:867\u2013873. doi: 10.3892/ijmm.2013.1274.", "ArticleIdList": ["10.3892/ijmm.2013.1274", "23403777"]}, {"Citation": "Fanhchaksai K., Kodchakorn K., Pothacharoen P., Kongtawelert P. Effect of sesamin against cytokine production from influenza type A H1N1-induced peripheral blood mononuclear cells: Computational and experimental studies. Vitr. Cell Dev. Biol. Anim. 2016;52:107\u2013119. doi: 10.1007/s11626-015-9950-7.", "ArticleIdList": ["10.1007/s11626-015-9950-7", "26424131"]}, {"Citation": "Ren R., Ci X.-X., Li H.-Z., Luo G.-J., Li R.-T., Deng X.-M. New Dibenzocyclooctadiene Lignans from Schisandra sphenanthera and Their Proinflammatory Cytokine Inhibitory Activities. Z. F\u00fcr Nat. B. 2014;65:8. doi: 10.1515/znb-2010-0201.", "ArticleIdList": ["10.1515/znb-2010-0201"]}, {"Citation": "Szopa A., Barna\u015b M., Ekiert H. Phytochemical studies and biological activity of three Chinese Schisandra species (Schisandra sphenanthera, Schisandra henryi and Schisandra rubriflora): Current findings and future applications. Phytochem. Rev. 2018;18:109\u2013128. doi: 10.1007/s11101-018-9582-0.", "ArticleIdList": ["10.1007/s11101-018-9582-0"]}, {"Citation": "Checker R., Patwardhan R., Sharma D., Menon J., Thoh M., Bhilwade H.N., Konishi T., Sandur S.K. Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-kappaB. Free Radic. Biol. Med. 2012;53:1421\u20131430. doi: 10.1016/j.freeradbiomed.2012.08.006.", "ArticleIdList": ["10.1016/j.freeradbiomed.2012.08.006", "22917978"]}, {"Citation": "Park S.Y., Park S.J., Park T.G., Rajasekar S., Lee S.-J., Choi Y.W. Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying/antioxidant enzymes in microglia. Int. Immunopharmacol. 2013;17:12. doi: 10.1016/j.intimp.2013.06.032.", "ArticleIdList": ["10.1016/j.intimp.2013.06.032", "23859871"]}, {"Citation": "Szopa A., Ekiert R., Ekiert H. Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: A review on the bioactive components, pharmacological properties, analytical and biotechnological studies. Phytochem. Rev. 2017;16:195\u2013218. doi: 10.1007/s11101-016-9470-4.", "ArticleIdList": ["10.1007/s11101-016-9470-4", "PMC5378736", "28424569"]}, {"Citation": "Liu H., Lai H., Jia X., Liu J., Zhang Z., Qi Y., Zhang J., Song J., Wu C., Zhang B., et al. Comprehensive chemical analysis of Schisandra chinensis by HPLC-DAD-MS combined with chemometrics. Phytomed. Int. J. Phytother. Phytopharm. 2013;20:9. doi: 10.1016/j.phymed.2013.05.001.", "ArticleIdList": ["10.1016/j.phymed.2013.05.001", "23880331"]}, {"Citation": "Yu J.-S., Wu Y.-H., Tseng C.-K., Lin C.-K., Hsu Y.-C., Chen Y.-H., Lee J.-C. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway. Sci. Rep. 2017;7:45171. doi: 10.1038/srep45171.", "ArticleIdList": ["10.1038/srep45171", "PMC5364541", "28338050"]}, {"Citation": "Xu L., Grandi N., Del Vecchio C., Mandas D., Corona A., Piano D., Esposito F., Parolin C., Tramontano E. From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors. J. Microbiol. 2015;53:6. doi: 10.1007/s12275-015-4652-0.", "ArticleIdList": ["10.1007/s12275-015-4652-0", "25740376"]}, {"Citation": "Liu G. Bicyclol: A Novel Drug for Treating Chronic Viral Hepatitis B and C. Med. Chem. 2009;5:29\u201343. doi: 10.2174/157340609787049316.", "ArticleIdList": ["10.2174/157340609787049316", "19149648"]}, {"Citation": "Zhang T. New drugs derived from medicinal plants. Th\u00e9rapie. 2016;57:14.", "ArticleIdList": ["12185962"]}, {"Citation": "Ruan B., Wang J., Bai X. Comparison of bicyclol therapy for patients with genotype B and C of hepatitis B virus. Chin. J. Exp. Clin. Virol. 2007;21:3.", "ArticleIdList": ["18322605"]}, {"Citation": "Huang M.-H., Li H., Xue R., Li J., Wang L., Cheng J., Wu Z., Li W., Chen J., Lv X., et al. Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication. Acta Pharm. Sin. B. 2019;9:769\u2013781. doi: 10.1016/j.apsb.2019.01.013.", "ArticleIdList": ["10.1016/j.apsb.2019.01.013", "PMC6663943", "31384537"]}, {"Citation": "Zhou Y., Chai X. Protective effect of bicyclol against pulmonary fibrosis via regulation of microRNA5 in rats. J. Cell. Biochem. 2019;121:651\u2013660. doi: 10.1002/jcb.29310.", "ArticleIdList": ["10.1002/jcb.29310", "31407409"]}, {"Citation": "Tian R.R., Xiao W.L., Yang L.M., Wang R.R., Sun H.D., Liu N.F., Zheng Y.T. The Isolation of Rubrifloralignan A and Its Anti-HIV-1 Activities. Chin. J. Nat. Med. 2006;4:40\u201344."}, {"Citation": "Chen M., Kilgore N., Lee K.-H., Chen D.-F. Rubrisandrins A and B, Lignans and Related Anti-HIV Compounds from Schisandra rubriflora. J. Nat. Prod. 2006;69:1697\u20131701. doi: 10.1021/np060239e.", "ArticleIdList": ["10.1021/np060239e", "17190445"]}, {"Citation": "Fujihashi T., Hara H., Sakata T., Mori K., Higuchi H., Tanaka A., Kaji H., Kaji A. Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptase. Antimicrob. Agents Chemother. 1995;39:2000\u20132007. doi: 10.1128/AAC.39.9.2000.", "ArticleIdList": ["10.1128/AAC.39.9.2000", "PMC162871", "8540706"]}, {"Citation": "Federico A., Dallio M., Loguercio C. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules. 2017;22:191. doi: 10.3390/molecules22020191.", "ArticleIdList": ["10.3390/molecules22020191", "PMC6155865", "28125040"]}, {"Citation": "Strader D.B., Bacon B.R., Lindsay K.L., La Brecque D.R., Morgan T., Wright E.C., Seeffff L.B. Use of complementary and alternative medicine in patients with liver disease. Am. J. Gastroenterol. 2002;97:7. doi: 10.1111/j.1572-0241.2002.05993.x.", "ArticleIdList": ["10.1111/j.1572-0241.2002.05993.x", "12358262"]}, {"Citation": "Liu C.-H., Jassey A., Hsu H.-Y., Lin L.-Z. Antiviral Activities of Silymarin and Derivatives. Molecules. 2019;24:1552. doi: 10.3390/molecules24081552.", "ArticleIdList": ["10.3390/molecules24081552", "PMC6514695", "31010179"]}, {"Citation": "Wagoner J., Negash A., Kane O.J., Martinez L.E., Nahmias Y., Bourne N., Owen D.M., Grove J., Brimacombe C., McKeating J.A., et al. Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology. 2010;51:1912\u20131921. doi: 10.1002/hep.23587.", "ArticleIdList": ["10.1002/hep.23587", "PMC2909978", "20512985"]}, {"Citation": "DebRoy S., Hiraga N., Imamura M., Hayes C.N., Akamatsu S., Canini L., Perelson A.S., Pohl R.T., Persiani S., Uprichard S.L. Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy. J. Viral Hepat. 2016;23:708\u2013717. doi: 10.1111/jvh.12551.", "ArticleIdList": ["10.1111/jvh.12551", "PMC4974116", "27272497"]}, {"Citation": "Song J.H., Choi H.J. Silymarin efficacy against influenza a virus replication. Phytomedicine. 2011;18:832\u2013835. doi: 10.1016/j.phymed.2011.01.026.", "ArticleIdList": ["10.1016/j.phymed.2011.01.026", "21377857"]}, {"Citation": "Li J., Meng A.-P., Guan X.-L., Li J., Wu Q., Deng S.-P., Su X.-J., Yang R.-Y. Anti-hepatitis B virus lignans from the root of Streblus asper. Bioorg. Med. Chem. Lett. 2013;23:2238\u20132244. doi: 10.1016/j.bmcl.2013.01.046.", "ArticleIdList": ["10.1016/j.bmcl.2013.01.046", "23434030"]}, {"Citation": "Lu X., Zhang W., Cheng X.-H., Wang H.-G., Yu D.-Y., Feng B.-M. Advances on the secolignans compounds in natural products. J. Shenyang Pharm. Univ. 2014;11:922. Available online:  http://en.cnki.com.cn/Article_en/CJFDTotal-SYYD201411019.htm."}, {"Citation": "Su X., Na L., Ning M.-M., Zhou C.-H., Yang Q.-R., Wang M.W. Bioactive Compounds from Peperomia pellucida. J. Nat. Prod. 2006;69:247\u2013250.", "ArticleIdList": ["16499324"]}, {"Citation": "Feng B.M., Qin H.H., Wang H.G., Shi L.Y., Yu D.Y., Ji B.Q., Zhao Q., Wang Y.Q. Three new secolignan glycosides from Urtica fissa E. Pritz. J. Nat. Med. 2012;66:562\u2013565. doi: 10.1007/s11418-011-0615-x.", "ArticleIdList": ["10.1007/s11418-011-0615-x", "22124934"]}, {"Citation": "Feng W.-S., Chen H., Zheng X.-K., Wang Y.-Z., Chen H., Li Z. Two new secolignans from Selaginella sinensis (Desv.) Spring. J. Asian Nat. Prod. Res. 2009;11:658\u2013662. doi: 10.1080/10286020902971011.", "ArticleIdList": ["10.1080/10286020902971011", "20183303"]}, {"Citation": "Cheng M.-J., Lee S.-J., Chang Y.-Y., Wu S.-H., Tsai I.-L., Jayaprakasam B., Chen I.-S. Chemical and cytotoxic constituents from Peperomia sui. Phytochemistry. 2003;63:603\u2013608. doi: 10.1016/S0031-9422(03)00183-3.", "ArticleIdList": ["10.1016/S0031-9422(03)00183-3", "12809722"]}, {"Citation": "Tsutsui C., Yamada Y., Ando M., Toyama D., Wu J.L., Wang L., Taketani S., Kataoka T. Peperomins as anti-inflammatory agents that inhibit the NF-kappaB signaling pathway. Bioorg. Med. Chem. Lett. 2009;19:4084\u20134087. doi: 10.1016/j.bmcl.2009.06.029.", "ArticleIdList": ["10.1016/j.bmcl.2009.06.029", "19559609"]}, {"Citation": "Govindachari T.R., Kumari G.N.K., Partho P.D. Two secolignans from Peperomia dindigulensis. Phytochemistry. 1998;49:2129\u20132131. doi: 10.1016/S0031-9422(98)00393-8.", "ArticleIdList": ["10.1016/S0031-9422(98)00393-8"]}, {"Citation": "Lin M., Yu D., Wang Q. Secolignans with Antiangiogenic Activities from Peperomia dindygulensis. Chem. Biodivers. 2011;8:862\u2013870. doi: 10.1002/cbdv.201000123.", "ArticleIdList": ["10.1002/cbdv.201000123", "21560234"]}, {"Citation": "Zhang G.-L., Li N., Wang Y.-H., Zheng Y.-T., Zhang Z., Wang M.-W. Bioactive lignans from Peperomia heyneana. J. Nat. Prod. 2007;70:662\u2013664. doi: 10.1021/np0605236.", "ArticleIdList": ["10.1021/np0605236", "17291043"]}]}], "History": [{"Year": "2019", "Month": "11", "Day": "8"}, {"Year": "2019", "Month": "12", "Day": "21"}, {"Year": "2019", "Month": "12", "Day": "23"}, {"Year": "2020", "Month": "1", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31906391", "PMC6982783", "10.3390/molecules25010183", "molecules25010183"]}}]}